首页行业分类医疗医药医药2023-04-27-国金证券-上海医药-疫后修复增长强劲,创新与国际化布局推进
PDF

2023-04-27-国金证券-上海医药-疫后修复增长强劲,创新与国际化布局推进

乐乐4页1.25M

下载文档
/4
全屏查看
2023-04-27-国金证券-上海医药-疫后修复增长强劲,创新与国际化布局推进
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
国金证券公司点评2020202120222023E2024E2025E2020202120222023E2024E2025E191,903215,824231,981257,203285,576319,84522,29622,39027,40149,85355.20961,76112.5%7.5%10.9%11.0%12.0%应收款项57,53163,42572,76276,88885,36895,612-164,474-187,281-201,45-222,113-246.131-275,66524.08827.10434.46033.46936.41440.02885.7%86.8%86.9%其他流动资产3.57514,89014,33614,69615,139毛利27,43528.54330.48635,09633,44544,179107,563116.494149,513174.545191,687212.54014.3%13.2%13.6%13.8%13.8%72.171.3%77.5%80.0%-716-797-8859928,06810.94711.93612.4661246812.471销售收入0.3%0.3%12,63413,80114,45414,84215,23015,617-12,85-13,318-14279-15.947-17,563-19,670625.9%6.7%6.217,17717,97718,38518,87619,33919,775-4.7325,143-4,9926.283-7.037非流动资产41.62345.94148.62250,7175202853.2892.5%2.4%2.252.2%28.7%24.522.5%21.3%研发费用-1,657-1,987-2,112-2.999-2,879149,186163.435198.135225,262243,714265.8280.9%1.11.123,10723.09731,00053.22156.93861,1927.4289,86411,71613,601应付款项49,93555,05868,04067,90975,23784.2334.0%3.4%9.09113.67011.65110.36610.87411.514-1,240-1,245-1,313-2,364-2,943-3,08688,13391,824110,691131,497143,049156,9390.61.1847.1586,2606.260-859-140-6440005,1285,3873,6783.7543,813117-20621994.445104,369120,132141,434153.063167.0119321.73345345050050045,35567,06371,68877.31284.27813.0%21.3%5.1462,8422,8423,6983,6983,987,1848.2059.0159.77612.816未分配利润25.05428.5993248037.10542,7293.8%3.93.9%10,93912,13913.33914.539营业外收支-62-20650-50-50149,186163,435198,135225.262243,714265,8287,1751448,8089,72611,02312,76638-1.570-1,869-1.816-2.237-2,535-2.9362020202120222023E2024E2025E21.9%23.0%20.623.0%23.0%23.0%5,6056.2756.9927,4898,4889,8301.5821.7921.5191.70019702.3331,1091,1811,3751,2001,2001,20015.95817.36718.13719.38320.90422.7875.0935.6177.2888.6302.4081.7811.2831.4421.93121862.3%2.4%2.4%2.6%0.4400.4800.4200.4500.4500.4509.91.323779.43%10.24%2020202120222023E2024E2025E3.12%84299%3.25%5,6056,2757.4898,4889.8306.905.26%5.82%1,1091,1811,3751,2001,2001,2003,1572,466432492542主营业务收入增长率12.46线710.87%12.00%-138-116-7621,3802,1052,3712.3-2.12%12.9117.60%18.78%16.10%-1,780-3.564-4.548-3.944-4.65810.17%13.2811.966,8455,0614,7435,3327,1418,0848.879.55%21.23%13.8.19%9.07%皆本开支-2.626-3,928-2.525180150150-2.364-1.651-10.274-53095.293.798.2100.0100.0100.0其他3,284-43632645050050054.349.955.855.054.053.0-1,706-12,47310064764771.868.375.075.075.075.014216914,12300因定产周特天数20.718.418.17.115.914.74.3323.83622,2373.7174.254其他-3,092-2,9365,820-4,7535,6195,88514.6013.31%0.310.01-1.805-3.97%-1.2611,56612,13917.484-1,903-16326142404456122,9167.10063.31s63.86线60.63%62.79%62.80%62.83%2